Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Independent of Mutation Status
Item
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) regardless of the mutation status
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0332291 (UMLS CUI [2,1])
C0026882 (UMLS CUI [2,2])
C0449438 (UMLS CUI [2,3])
Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease
Item
inclusion at the time of diagnostic or at relapse
boolean
C1512693 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C2348792 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
Neoplasm Biopsy
Item
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
boolean
C0027651 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Therapeutic procedure Before Liquid Biopsy
Item
patients treated before their liquid biopsy
boolean
C0087111 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C4505151 (UMLS CUI [1,3])
Cohort Number | Inclusion criteria
Item
cohort 2 inclusion criteria
boolean
C0599755 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C1512693 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Molecular Abnormality Quantity | EGFR gene mutation | BRAF gene mutation | HER2 Gene Mutation | ALK Gene Translocation | ROS1 Gene Translocation | MET Gene Amplification
Item
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) with one of the following molecular anomalies: epidermal growth factor receptor (egfr), b-raf proto oncogene (braf) or human epidermal growth factor receptor-2 (her2) mutations, anaplatsic lymphoma kinase (alk) or ros porto-oncogene 1 (ros1) translocation, mesenchymal-epithelial transition factor (met) amplification.
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C1704257 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C3266992 (UMLS CUI [3])
C1511021 (UMLS CUI [4])
C3273087 (UMLS CUI [5])
C4329227 (UMLS CUI [6])
C4331215 (UMLS CUI [7])
C1711106 (UMLS CUI [8])
Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease
Item
inclusion at the time of diagnostic or at relapse
boolean
C1512693 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C2348792 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
Neoplasm Biopsy
Item
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
boolean
C0027651 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Therapeutic procedure Before Liquid Biopsy
Item
patients treated before their liquid biopsy
boolean
C0087111 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C4505151 (UMLS CUI [1,3])